Replicating adenovirus vector prime/protein boost strategies for HIV vaccine development
- 11 August 2008
- journal article
- review article
- Published by Informa Healthcare in Expert Opinion on Biological Therapy
- Vol. 8 (9) , 1347-1363
- https://doi.org/10.1517/14712598.8.9.1347
Abstract
Background: In recent years the HIV vaccine field introduced a number of promising vaccine candidates into human clinical trials. Objective: To briefly discuss the advances made in vaccine developm...Keywords
This publication has 160 references indexed in Scilit:
- An HIV-1 clade C DNA prime, NYVAC boost vaccine regimen induces reliable, polyfunctional, and long-lasting T cell responsesThe Journal of Experimental Medicine, 2008
- Replicating and non-replicating viral vectors for vaccine developmentCurrent Opinion in Biotechnology, 2007
- Broad HIV-1 neutralization mediated by CD4-binding site antibodiesNature Medicine, 2007
- Heterologous Prime/Boost Immunization of Rhesus Monkeys by Using Diverse Poxvirus VectorsJournal of Virology, 2007
- Phase 2 Study of an HIV-1 Canarypox Vaccine (vCP1452) Alone and in Combination With rgp120JAIDS Journal of Acquired Immune Deficiency Syndromes, 2007
- Phase 1 Safety and Immunogenicity Evaluation of a Multiclade HIV‐1 DNA Candidate VaccineThe Journal of Infectious Diseases, 2006
- Phase 1 Safety and Immunogenicity Evaluation of a Multiclade HIV‐1 Candidate Vaccine Delivered by a Replication‐Defective Recombinant Adenovirus VectorThe Journal of Infectious Diseases, 2006
- Neurovirulence properties of recombinant vesicular stomatitis virus vectors in non-human primatesVirology, 2006
- Efficient protein boosting after plasmid DNA or recombinant adenovirus immunization with HIV-1 vaccine constructsVaccine, 2006
- Preserved CD4+ Central Memory T Cells and Survival in Vaccinated SIV-Challenged MonkeysScience, 2006